Central Nervous System Non-Von Hippel-Lindau (VHL) Hemangioblastoma Evolving to Dissemination: Is Anti-Angiogenic Therapy an Option? acmcr. 2021;5(2):303-313. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22480